{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:42:49Z","timestamp":1792215769567,"version":"4.4.0"},"reference-count":261,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Neovascular age-related macular degeneration (exudative or wet AMD) is a prevalent, progressive retinal degenerative macular disease that is characterized by neovascularization of the choroid, mainly affecting the elderly population causing gradual vision impairment. Risk factors such as age, race, genetics, iris color, smoking, drinking, BMI, and diet all play a part in nvAMD\u2019s progression, with anti-vascular endothelial growth factor (anti-VEGF) therapy being the mainstay of treatment. Current therapeutic advancements slow the progression of the disease but do not cure or reverse its course. Newer therapies such as gene therapies, Rho-kinase inhibitors, and levodopa offer potential new targets for treatment.<\/jats:p>","DOI":"10.3390\/ijms22031170","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T09:59:40Z","timestamp":1611568780000},"page":"1170","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":141,"title":["Neovascular Macular Degeneration: A Review of Etiology, Risk Factors, and Recent Advances in Research and Therapy"],"prefix":"10.3390","volume":"22","author":[{"given":"Arunbalaji","family":"Pugazhendhi","sequence":"first","affiliation":[{"name":"Knights Campus for Accelerating Scientific Impact, University of Oregon, Eugene, OR 97403, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Hubbell","sequence":"additional","affiliation":[{"name":"Knights Campus for Accelerating Scientific Impact, University of Oregon, Eugene, OR 97403, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Jairam","sequence":"additional","affiliation":[{"name":"Vagelos College of Physicians &amp; Surgeons, Columbia Irving Medical Center, Columbia University, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balamurali","family":"Ambati","sequence":"additional","affiliation":[{"name":"Knights Campus for Accelerating Scientific Impact, University of Oregon, Eugene, OR 97403, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/ceo.13343","article-title":"Role of diet and food intake in age-related macular degeneration: A systematic review","volume":"47","author":"Chapman","year":"2019","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1515\/CCLM.2011.091","article-title":"Age-related macular degeneration: Genetic and clinical findings","volume":"49","author":"Kokotas","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Age-Related Eye Disease Study Research Group (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol., 119, 1417\u20131436.","DOI":"10.1001\/archopht.119.10.1417"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Age-Related Eye Disease Study Research Group (2000). Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology, 107, 2224\u20132232.","DOI":"10.1016\/S0161-6420(00)00409-7"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archopht.123.11.1484","article-title":"The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17","volume":"123","author":"Davis","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(08)61759-6","article-title":"Age-related macular degeneration","volume":"372","author":"Coleman","year":"2008","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"(2001). The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: The Age-Related Eye Disease Study Report Number 6. Am. J. Ophthalmol., 132, 668\u2013681.","DOI":"10.1016\/S0002-9394(01)01218-1"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00055735-200206000-00007","article-title":"Risk factors for age-related macular degeneration: An update","volume":"13","author":"Hyman","year":"2002","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1167\/iovs.14-14299","article-title":"Nongenetic Risk Factors for Neovascular Age-Related Macular Degeneration","volume":"55","author":"Ristau","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"895147","DOI":"10.1155\/2013\/895147","article-title":"Smoking and age-related macular degeneration: Review and update","volume":"2013","author":"Velilla","year":"2013","journal-title":"J. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.118.3.351","article-title":"Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group","volume":"118","author":"Hyman","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","article-title":"Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: A meta-analysis","volume":"119","author":"Rudnicka","year":"2012","journal-title":"Ophthalmology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.exer.2007.03.011","article-title":"Age-related changes in human macular Bruch\u2019s membrane as seen by quick-freeze\/deep-etch","volume":"85","author":"Huang","year":"2007","journal-title":"Exp. Eye Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1600-0420.2005.00492.x","article-title":"Risk factors for age-related maculopathy in a 14-year follow-up study: The Copenhagen City Eye Study","volume":"83","author":"Buch","year":"2005","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fgene.2017.00216","article-title":"The Aging Risk and Atherosclerosis: A Fresh Look at Arterial Homeostasis","volume":"8","author":"Head","year":"2017","journal-title":"Front. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.preteyeres.2012.04.004","article-title":"Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease","volume":"31","author":"Kur","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/oxfordjournals.aje.a117648","article-title":"Age-related Macular Degeneration Is Associated with Atherosclerosis: The Rotterdam Study","volume":"142","author":"Vingerling","year":"1995","journal-title":"Am. J. Epidemiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.arr.2016.01.007","article-title":"Hypertension and aging","volume":"26","author":"Buford","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0161-6420(99)90267-1","article-title":"Racial differences in the prevalence of age-related macular degeneration: The Baltimore eye survey","volume":"106","author":"Friedman","year":"1999","journal-title":"Ophthalmology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archophthalmol.2007.53","article-title":"The Salisbury Eye Evaluation (SEE) Study Team. Racial Differences in the Prevalence of Age-Related Macular Degeneration: The Salisbury Eye Evaluation (SEE) Project","volume":"126","author":"Bressler","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ophtha.2004.10.047","article-title":"Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19","volume":"112","author":"Clemons","year":"2005","journal-title":"Ophthalmology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ophtha.2005.12.013","article-title":"Prevalence of age-related macular degeneration in 4 racial\/ethnic groups in the multi-ethnic study of atherosclerosis","volume":"113","author":"Klein","year":"2006","journal-title":"Ophthalmology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archopht.123.11.1575","article-title":"Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER","volume":"123","author":"Klein","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0161-6420(92)31871-8","article-title":"Prevalence of age-related maculopathy. The Beaver Dam Eye Study","volume":"99","author":"Klein","year":"1992","journal-title":"Ophthalmology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0161-6420(99)90255-5","article-title":"Age-related maculopathy in a multiracial United States population: The National Health and Nutrition Examination Survey III","volume":"106","author":"Klein","year":"1999","journal-title":"Ophthalmology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.ophtha.2004.01.023","article-title":"Prevalence of age-related macular degeneration in Latinos: The Los Angeles Latino eye study","volume":"111","author":"Varma","year":"2004","journal-title":"Ophthalmology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/bjo.85.10.1153","article-title":"Prevalence of age related maculopathy in a representative Japanese population: The Hisayama study","volume":"85","author":"Oshima","year":"2001","journal-title":"Br. J. Ophthalmol."},{"key":"ref_29","first-page":"2734","article-title":"Iris pigmentation and extent of disease in patients with neovascular age-related macular degeneration","volume":"35","author":"Sandberg","year":"1994","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1442-9071.2003.00711.x","article-title":"Iris colour, ethnic origin and progression of age-related macular degeneration","volume":"31","author":"Nicolas","year":"2003","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/S0161-6420(03)00539-6","article-title":"The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: The Beaver Dam Eye Study","volume":"110","author":"Tomany","year":"2003","journal-title":"Ophthalmology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/08820538.2011.577129","article-title":"Genetics of age-related macular degeneration: Current concepts, future directions","volume":"26","author":"Deangelis","year":"2011","journal-title":"Semin. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jamaophthalmol.2016.0669","article-title":"Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"134","author":"Maguire","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archopht.120.10.1357","article-title":"Smoking and the 5-Year Incidence of Age-Related Maculopathy: The Blue Mountains Eye Study","volume":"120","author":"Mitchell","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ophtha.2006.10.040","article-title":"Fifteen-year cumulative incidence of age-related macular degeneration: The Beaver Dam Eye Study","volume":"114","author":"Klein","year":"2007","journal-title":"Ophthalmology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/oxfordjournals.aje.a009421","article-title":"Relation of Smoking to the Incidence of Age-related Maculopathy: The Beaver Dam Eye Study","volume":"147","author":"Klein","year":"1998","journal-title":"Am. J. Epidemiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/aje\/kwf092","article-title":"Ten-Year Incidence of Age-related Maculopathy and Smoking and Drinking: The Beaver Dam Eye Study","volume":"156","author":"Klein","year":"2002","journal-title":"Am. J. Epidemiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.eye.6701978","article-title":"Smoking and age-related macular degeneration: A review of association","volume":"19","author":"Thornton","year":"2005","journal-title":"Eye"},{"key":"ref_39","first-page":"939","article-title":"Effects of cigarette smoking on ocular circulation chronic effect on choroidal circulation","volume":"95","author":"Hara","year":"1991","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Fields, M.A., Bowrey, H.E., Gong, J., Moreira, E.F., Cai, H., and Del Priore, L.V. (2017). Extracellular matrix nitration alters growth factor release and activates bioactive complement in human retinal pigment epithelial cells. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177763"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Fujihara, M., Nagai, N., Sussan, T.E., Biswal, S., and Handa, J.T. (2008). Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003119"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0161-6420(00)00580-7","article-title":"Risk factors for age-related macular degeneration: Pooled findings from three continents","volume":"108","author":"Smith","year":"2001","journal-title":"Ophthalmology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bjo.2005.073643","article-title":"Smoking and age related macular degeneration: The number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation","volume":"90","author":"Khan","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"ref_44","first-page":"3507","article-title":"Cigarette Smoke Increases Severity of Experimental Choroidal Neovascularization (CNV): Role of Inflammation","volume":"46","author":"Suner","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.lfs.2012.06.032","article-title":"Nicotine and pathological angiogenesis","volume":"91","author":"Lee","year":"2012","journal-title":"Life Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1167\/iovs.07-1584","article-title":"Racial Differences and Other Risk Factors for Incidence and Progression of Age-Related Macular Degeneration: Salisbury Eye Evaluation (SEE) Project","volume":"49","author":"Chang","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1253\/circj.71.418","article-title":"Cigarette-smoke-induced vasoconstriction of peripheral arteries: Evaluation by synchrotron radiation microangiography","volume":"71","author":"Akishima","year":"2007","journal-title":"Circ. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0891-5849(89)90029-4","article-title":"Role of lipid peroxidation and oxidative stress in alcohol toxicity","volume":"7","author":"Cederbaum","year":"1989","journal-title":"Free Radic. Biol. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ajo.2007.12.005","article-title":"Alcohol consumption and the risk of age-related macular degeneration: A systematic review and meta-analysis","volume":"145","author":"Chong","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ajo.2006.04.015","article-title":"Risk Factors for Five-Year Incident Age-related Macular Degeneration: The Reykjavik Eye Study","volume":"142","author":"Arnarsson","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ajo.2009.07.025","article-title":"The Association of Smoking and Alcohol Use With Age-related Macular Degeneration in the Oldest Old: The Study of Osteoporotic Fractures","volume":"149","author":"Coleman","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ajo.2007.01.036","article-title":"Alcohol consumption and the 15-year cumulative incidence of age-related macular degeneration","volume":"143","author":"Knudtson","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/aje\/kws004","article-title":"20\/20\u2014Alcohol and Age-related Macular Degeneration: The Melbourne Collaborative Cohort Study","volume":"176","author":"Adams","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/met.2015.0095","article-title":"Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies","volume":"13","author":"Manna","year":"2015","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1167\/iovs.15-18637","article-title":"Overweight, Obesity, and Risk of Age-Related Macular Degeneration","volume":"57","author":"Zhang","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1167\/iovs.13-13763","article-title":"Measures of body shape and adiposity as related to incidence of age-related eye diseases: Observations from the Beaver Dam Eye Study","volume":"55","author":"Howard","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archopht.1996.01100140393005","article-title":"Age-Related Macular Degeneration and Smoking: The Rotterdam Study","volume":"114","author":"Vingerling","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0300-483X(02)00386-4","article-title":"The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients","volume":"180","author":"Alberg","year":"2002","journal-title":"Toxicology"},{"key":"ref_59","first-page":"79","article-title":"Association of age-related macular degeneration with complement activation products, smoking, and single nucleotide polymorphisms in South Carolinians of European and African descent","volume":"25","author":"Rohrer","year":"2019","journal-title":"Mol. Vis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2011.01.003","article-title":"The role of nicotine in the pathogenesis of atherosclerosis","volume":"215","author":"Lee","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1096\/fj.00-0650rev","article-title":"Current concepts in the pathogenesis of alcoholic liver injury","volume":"15","author":"Tsukamoto","year":"2001","journal-title":"FASEB J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/ijms16010378","article-title":"Oxidative stress in obesity: A critical component in human diseases","volume":"16","author":"Marseglia","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3945\/ajcn.2008.26528","article-title":"Association between adherence to the Mediterranean diet and oxidative stress","volume":"88","author":"Dai","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Cougnard-Gr\u00e9goire, A., Merle, B.M., Korobelnik, J.F., Rougier, M.B., Delyfer, M.N., Le Goff, M., Samieri, C., Dartigues, J.F., and Delcourt, C. (2016). Olive Oil Consumption and Age-Related Macular Degeneration: The Alienor Study. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160240"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3945\/ajcn.115.111047","article-title":"Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: A prospective cohort study","volume":"102","author":"Merle","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajo.2014.04.016","article-title":"The relationship of major American dietary patterns to age-related macular degeneration","volume":"158","author":"Chiu","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/NT.0000000000000228","article-title":"Mediterranean Diet and Prevention of Chronic Diseases","volume":"52","author":"Romagnolo","year":"2017","journal-title":"Nutr. Today"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/nu6010231","article-title":"The Mediterranean diet and nutritional adequacy: A review","volume":"6","year":"2014","journal-title":"Nutrients"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1017\/S0007114509990559","article-title":"Dietary patterns and nutritional adequacy in a Mediterranean country","volume":"101","author":"Pfrimer","year":"2009","journal-title":"Br. J. Nutr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1478-7954-10-22","article-title":"National, regional, and global trends in adult overweight and obesity prevalences","volume":"10","author":"Stevens","year":"2012","journal-title":"Popul. Health Metr."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/07315724.2012.10720024","article-title":"Relation between eating habits and a high body mass index among freshman students: A cross-sectional study","volume":"31","author":"Gunes","year":"2012","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"20723","DOI":"10.1038\/srep20723","article-title":"Dietary n-3 Fatty Acid, \u03b1-Tocopherol, Zinc, vitamin D, vitamin C and \u03b2-carotene are Associated with Age-Related Macular Degeneration in Japan","volume":"6","author":"Aoki","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ophtha.2016.09.019","article-title":"Mediterranean Diet Score and Its Association with Age-Related Macular Degeneration: The European Eye Study","volume":"124","author":"Hogg","year":"2017","journal-title":"Ophthalmology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/archopht.125.5.671","article-title":"The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20","volume":"125","author":"SanGiovanni","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"ref_75","first-page":"443","article-title":"The relationships of age changes in retinal pigment epithelium and Bruch\u2019s membrane","volume":"40","author":"Okubo","year":"1999","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2147\/CIA.S143508","article-title":"Recent developments in age-related macular degeneration: A review","volume":"12","author":"Yassin","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"8374647","DOI":"10.1155\/2018\/8374647","article-title":"Age-Related Macular Degeneration: New Paradigms for Treatment and Management of AMD","volume":"2018","author":"Zenteno","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_78","unstructured":"Purves, D., Augustine, G.J., Fitzpatrick, D., Katz, L.C., LaMantia, A.-S., McNamara, J.-O., and Williams, M. (2001). Anatomical Distribution of Rods and Cones. Neuroscience, Sinauer Associates. [2th ed.]."},{"key":"ref_79","first-page":"8","article-title":"Phagocytosis of retinal rod and cone photoreceptors","volume":"25","author":"Kevany","year":"2010","journal-title":"Physiology (Bethesda)"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0891-5849(02)00959-0","article-title":"Lipofuscin: Mechanisms of age-related accumulation and influence on cell","volume":"33","author":"Brunk","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0167-4943(02)00005-5","article-title":"What is lipofuscin? Defining characteristics and differentiation from other autofluorescent lysosomal storage bodies","volume":"34","author":"Katz","year":"2002","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1194\/jlr.R000687","article-title":"Phospholipid meets all-trans-retinal: The making of RPE bisretinoids","volume":"51","author":"Sparrow","year":"2010","journal-title":"J. Lipid. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/eye.1995.192","article-title":"Lipofuscin of the retinal pigment epithelium: A review","volume":"9","author":"Kennedy","year":"1995","journal-title":"Eye (Lond)"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1073\/pnas.052025899","article-title":"The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium","volume":"99","author":"Finnemann","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_85","first-page":"353","article-title":"Age-related macular degeneration (AMD): Pathogenesis and therapy","volume":"58","author":"Nowak","year":"2006","journal-title":"Pharm. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Wang, L., Clark, M.E., Crossman, D.K., Kojima, K., Messinger, J.D., Mobley, J.A., and Curcio, C.A. (2010). Abundant Lipid and Protein Components of Drusen. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010329"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nri3459","article-title":"Immunology of age-related macular degeneration","volume":"13","author":"Ambati","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ejhg.2015.247","article-title":"Common coding variants in the HLA-DQB1 region confer susceptibility to age-related macular degeneration","volume":"24","author":"Jorgenson","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.12659\/MSM.889887","article-title":"Age-related macular degeneration and changes in the extracellular matrix","volume":"20","author":"Nita","year":"2014","journal-title":"Med. Sci. Monit."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1096\/fasebj.14.7.835","article-title":"Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease","volume":"14","author":"Mullins","year":"2000","journal-title":"FASEB J."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/09273940590909185","article-title":"Immunological factors in the pathogenesis and treatment of age-related macular degeneration","volume":"13","author":"Kijlstra","year":"2005","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s00018-004-4080-5","article-title":"Accumulation of oxidized lipid-protein complexes alters phagosome maturation in retinal pigment epithelium","volume":"61","author":"Hoppe","year":"2004","journal-title":"Cell. Mol. Life. Sci."},{"key":"ref_93","first-page":"4146","article-title":"Role of A2E in the Pathogenesis of CNV","volume":"47","author":"Iriyama","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv. Ophthalmol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3390\/nu5061962","article-title":"Macular pigment and its contribution to vision","volume":"5","author":"Loskutova","year":"2013","journal-title":"Nutrients"},{"key":"ref_96","first-page":"28","article-title":"The potential role of oxidative stress in the pathogenesis of the age-related macular degeneration (AMD)","volume":"61","author":"Karczewicz","year":"2007","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"ref_97","first-page":"333","article-title":"Pathogenesis and prophylaxis of AMD: Focus on oxidative stress and antioxidants","volume":"64","author":"Nowak","year":"2010","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/0042-6989(96)00008-9","article-title":"Cigarette smoking and retinal carotenoids: Implications for age-related macular degeneration","volume":"36","author":"Hammond","year":"1996","journal-title":"Vis. Res"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1001\/jamaophthalmol.2015.3590","article-title":"Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up","volume":"133","author":"Wu","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41419-018-0331-5","article-title":"Light action spectrum on oxidative stress and mitochondrial damage in A2E-loaded retinal pigment epithelium cells","volume":"9","author":"Marie","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jcp.21698","article-title":"Oxidative stress promotes ocular neovascularization","volume":"219","author":"Dong","year":"2009","journal-title":"J. Cell Physiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/15216540051081010","article-title":"Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems","volume":"50","author":"Davies","year":"2000","journal-title":"IUBMB Life"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1167\/iovs.05-0719","article-title":"Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD","volume":"47","author":"Suner","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_104","first-page":"993","article-title":"A Comparison of Carotenoids, Retinoids, and Tocopherols in the Serum and Buccal Mucosa of Chronic Cigarette Smokers versus Nonsmokers","volume":"15","author":"Gabriel","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Amplif. Amplif. Prev."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1749-6632.1993.tb39195.x","article-title":"Smoking, Alcohol, and Plasma Levels of Carotenes and Vitamin Ea","volume":"686","author":"Rimm","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/nar\/gkp100","article-title":"Oxidative stress induces degradation of mitochondrial DNA","volume":"37","author":"Shokolenko","year":"2009","journal-title":"Nucleic. Acids Res."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Hoh Kam, J., Lenassi, E., and Jeffery, G. (2010). Viewing ageing eyes: Diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013127"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2016.02.002","article-title":"TGF-\u03b21 prevents rat retinal insult induced by amyloid-\u03b2 (1-42) oligomers","volume":"787","author":"Fisichella","year":"2016","journal-title":"Eur. J. Pharm."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/cdd.2017.44","article-title":"Caspases and their substrates","volume":"24","author":"Julien","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.immuni.2019.05.020","article-title":"Caspases in Cell Death, Inflammation, and Disease","volume":"50","author":"Lamkanfi","year":"2019","journal-title":"Immunity"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Lamkanfi, M., and Dixit, V.M. (2009). The Inflammasomes. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000510"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The Inflammasome: A Molecular Platform Triggering Activation of Inflammatory Caspases and Processing of proIL-\u03b2","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41598-017-17634-1","article-title":"Issues with the Specificity of Immunological Reagents for NLRP3: Implications for Age-related Macular Degeneration","volume":"8","author":"Kosmidou","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"447s","DOI":"10.1093\/ajcn\/83.2.447S","article-title":"Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process","volume":"83","author":"Dinarello","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Kelley, N., Jeltema, D., Duan, Y., and He, Y. (2019). The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133328"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.4049\/jimmunol.0902425","article-title":"Inflammasome-associated nucleotide-binding domain, leucine-rich repeat proteins and inflammatory diseases","volume":"183","author":"Jha","year":"2009","journal-title":"J. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fphys.2014.00114","article-title":"The role IL-1 in tumor-mediated angiogenesis","volume":"5","author":"Voronov","year":"2014","journal-title":"Front. Physiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1111\/bph.12876","article-title":"IL-1\u03b2 and IL-18: Inflammatory markers or mediators of hypertension?","volume":"171","author":"Krishnan","year":"2014","journal-title":"Br. J. Pharm."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3389\/fimmu.2019.01426","article-title":"IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis","volume":"10","author":"Fahey","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2567.2004.01784.x","article-title":"Efficient induction of T helper type 1-mediated immune responses in antigen-primed mice by anti-CD3 single-chain Fv\/interleukin-18 fusion DNA","volume":"111","author":"Kim","year":"2004","journal-title":"Immunology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","article-title":"Interleukin-18 regulates both Th1 and Th2 responses","volume":"19","author":"Nakanishi","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm.2717","article-title":"NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components","volume":"18","author":"Doyle","year":"2012","journal-title":"Nat. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cyto.2012.06.014","article-title":"New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation","volume":"59","author":"Bamias","year":"2012","journal-title":"Cytokine"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Anderson, O.A., Finkelstein, A., and Shima, D.T. (2013). A2E induces IL-1\u00df production in retinal pigment epithelial cells via the NLRP3 inflammasome. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067263"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1167\/iovs.12-10849","article-title":"Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: Implications for inflammasome activation in age-related macular degeneration","volume":"54","author":"Liu","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2012.05.005","article-title":"Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells--implications for age-related macular degeneration (AMD)","volume":"147","author":"Kauppinen","year":"2012","journal-title":"Immunol. Lett."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.celrep.2013.08.002","article-title":"NLRP3 inflammasome blockade inhibits VEGF-A-induced age-related macular degeneration","volume":"4","author":"Marneros","year":"2013","journal-title":"Cell Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.immuni.2012.06.013","article-title":"Cell volume regulation modulates NLRP3 inflammasome activation","volume":"37","author":"Compan","year":"2012","journal-title":"Immunity"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bcp.2017.05.001","article-title":"P2X7 receptor antagonism: Implications in diabetic retinopathy","volume":"138","author":"Platania","year":"2017","journal-title":"Biochem. Pharm."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1073\/pnas.1403814111","article-title":"DICER1\/Alu RNA dysmetabolism induces Caspase-8\u2013mediated cell death in age-related macular degeneration","volume":"111","author":"Kim","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2012.03.036","article-title":"DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88","volume":"149","author":"Tarallo","year":"2012","journal-title":"Cell"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1093\/nar\/gkl706","article-title":"Alu elements as regulators of gene expression","volume":"34","author":"Strub","year":"2006","journal-title":"Nucleic. Acids Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/35053110","article-title":"Role for a bidentate ribonuclease in the initiation step of RNA interference","volume":"409","author":"Bernstein","year":"2001","journal-title":"Nature"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1073\/pnas.0711506105","article-title":"Structural and biochemical insights into the dicing mechanism of mouse Dicer: A conserved lysine is critical for dsRNA cleavage","volume":"105","author":"Du","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature09830","article-title":"DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration","volume":"471","author":"Kaneko","year":"2011","journal-title":"Nature"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1073\/pnas.1909761117","article-title":"Chronic Dicer1 deficiency promotes atrophic and neovascular outer retinal pathologies in mice","volume":"117","author":"Wright","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1073\/pnas.0408835103","article-title":"Drusen complement components C3a and C5a promote choroidal neovascularization","volume":"103","author":"Nozaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"16182","DOI":"10.1073\/pnas.0604255103","article-title":"Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium","volume":"103","author":"Zhou","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","article-title":"Mechanisms of age-related macular degeneration","volume":"75","author":"Ambati","year":"2012","journal-title":"Neuron"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1167\/iovs.03-0038","article-title":"Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization","volume":"44","author":"Suner","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1167\/iovs.03-0097","article-title":"Macrophage depletion inhibits experimental choroidal neovascularization","volume":"44","author":"Sakurai","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm950","article-title":"An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice","volume":"9","author":"Ambati","year":"2003","journal-title":"Nat. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.0105-2896.2004.00205.x","article-title":"Induction of allergic inflammation by interleukin-18 in experimental animal models","volume":"202","author":"Tsutsui","year":"2004","journal-title":"Immunol. Rev."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: In vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.celrep.2015.01.050","article-title":"ROCK-isoform-specific polarization of macrophages associated with age-related macular degeneration","volume":"10","author":"Zandi","year":"2015","journal-title":"Cell Rep."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10456-013-9381-6","article-title":"Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo","volume":"17","author":"Jetten","year":"2014","journal-title":"Angiogenesis"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/archopht.126.6.782","article-title":"Effect of Bevacizumab on Inflammation and Proliferation in Human Choroidal Neovascularization","volume":"126","author":"Tatar","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/ATVBAHA.109.186742","article-title":"Inhibition of VEGF or TGF-{beta} signaling activates endothelium and increases leukocyte rolling","volume":"29","author":"Walshe","year":"2009","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nm988","article-title":"Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer","volume":"10","author":"Willett","year":"2004","journal-title":"Nat. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1073\/pnas.1616166114","article-title":"Structural basis of Tie2 activation and Tie2\/Tie1 heterodimerization","volume":"114","author":"Saharinen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","article-title":"Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning","volume":"87","author":"Davis","year":"1996","journal-title":"Cell"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcp.20292","article-title":"Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization","volume":"204","author":"Nambu","year":"2005","journal-title":"J. Cell Physiol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm1351","article-title":"Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation","volume":"12","author":"Fiedler","year":"2006","journal-title":"Nat. Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"a006550","DOI":"10.1101\/cshperspect.a006650","article-title":"The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway","volume":"2","author":"Thurston","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"45081","DOI":"10.1038\/srep45081","article-title":"Elevated angiopoietin 2 in aqueous of patients with neovascular age related macular degeneration correlates with disease severity at presentation","volume":"7","author":"Ng","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ajo.2004.10.004","article-title":"Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy","volume":"139","author":"Watanabe","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ophtha.2019.03.023","article-title":"Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial","volume":"126","author":"Sahni","year":"2019","journal-title":"Ophthalmology"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0006-291X(89)92678-8","article-title":"Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells","volume":"161","author":"Ferrara","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/9467","article-title":"VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation","volume":"5","author":"Gerber","year":"1999","journal-title":"Nat. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00109-002-0397-4","article-title":"The role of VEGF in normal and neoplastic hematopoiesis","volume":"81","author":"Gerber","year":"2003","journal-title":"J. Mol. Med. (Berl.)"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/wound.2013.0517","article-title":"Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair","volume":"3","author":"Johnson","year":"2014","journal-title":"Adv. Wound Care (New Rochelle)"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/j.1460-2075.1996.tb00359.x","article-title":"A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases","volume":"15","author":"Joukov","year":"1996","journal-title":"EMBO J."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature04479","article-title":"Endothelial cells and VEGF in vascular development","volume":"438","author":"Coultas","year":"2005","journal-title":"Nature"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.3816\/CBC.2000.s.015","article-title":"The role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGF-receptor kinase inhibitors","volume":"1","author":"Verheul","year":"2000","journal-title":"Clin. Breast Cancer"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1357-2725(01)00027-9","article-title":"Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D","volume":"33","author":"Li","year":"2001","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen","volume":"246","author":"Leung","year":"1989","journal-title":"Science"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1074\/jbc.M110.175158","article-title":"Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: Identification of a specific {alpha}9{beta}1 binding site","volume":"286","author":"Oommen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","article-title":"VEGFs and receptors involved in angiogenesis versus lymphangiogenesis","volume":"21","author":"Lohela","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2353\/ajpath.2010.090878","article-title":"The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization","volume":"177","author":"Hartmann","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Rossino, M.G., Lulli, M., Amato, R., Cammalleri, M., Monte, M.D., and Casini, G. (2020). Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy. Cells, 9.","DOI":"10.3390\/cells9061452"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/sj.onc.1201380","article-title":"p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells","volume":"15","author":"Rousseau","year":"1997","journal-title":"Oncogene"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1073\/pnas.041359198","article-title":"Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability","volume":"98","author":"Fukumura","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1523-1755.2005.00575.x","article-title":"VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells","volume":"68","author":"Feliers","year":"2005","journal-title":"Kidney Int."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"C1448","DOI":"10.1152\/ajpcell.2001.281.5.C1448","article-title":"Role of PLCgamma and Ca(2+) in VEGF- and FGF-induced choroidal endothelial cell proliferation","volume":"281","author":"McLaughlin","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.CIR.97.1.99","article-title":"Vascular endothelial growth factor\/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin","volume":"97","author":"Murohara","year":"1998","journal-title":"Circulation"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000324751","article-title":"Role of the cytoskeleton in formation and maintenance of angiogenic sprouts","volume":"48","author":"Bayless","year":"2011","journal-title":"J. Vasc. Res."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0092-8674(03)00120-X","article-title":"Cellular Motility Driven by Assembly and Disassembly of Actin Filaments","volume":"112","author":"Pollard","year":"2003","journal-title":"Cell"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/mt.2013.243","article-title":"Repression of Choroidal Neovascularization Through Actin Cytoskeleton Pathways by MicroRNA-24","volume":"22","author":"Zhou","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.ATV.20.3.659","article-title":"Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells","volume":"20","author":"Dulak","year":"2000","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2170\/physiolsci.RP002305","article-title":"Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis","volume":"56","author":"Kuwabara","year":"2006","journal-title":"J. Physiol. Sci."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jcp.10026","article-title":"Novel mechanism for age-related macular degeneration: An equilibrium shift between the angiogenesis factors VEGF and PEDF","volume":"189","author":"Morita","year":"2001","journal-title":"J. Cell Physiol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1006\/bbrc.1993.1671","article-title":"Synthesis and secretion of vascular permeability factor\/vascular endothelial growth factor by human retinal pigment epithelial cells","volume":"193","author":"Adamis","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":"Pigment epithelium-derived factor: A potent inhibitor of angiogenesis","volume":"285","author":"Dawson","year":"1999","journal-title":"Science"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1074\/jbc.M507401200","article-title":"Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1","volume":"281","author":"Cai","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.4161\/auto.36184","article-title":"Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD","volume":"10","author":"Mitter","year":"2014","journal-title":"Autophagy"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0002-9394(02)01549-0","article-title":"Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration","volume":"134","author":"Holekamp","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"ref_191","first-page":"821","article-title":"Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth","volume":"43","author":"Duh","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Macular Photocoagulation Study Group (1982). Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch. Ophthalmol., 100, 912\u2013918.","DOI":"10.1001\/archopht.1982.01030030920003"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Macular Photocoagulation Study Group (1990). Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch. Ophthalmol., 108, 816\u2013824.","DOI":"10.1001\/archopht.1990.01070080058036"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00417-002-0517-4","article-title":"Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes","volume":"240","author":"Viestenz","year":"2002","journal-title":"Graefe\u2018s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/08820539909056057","article-title":"Principles of treatment of choroidal neovascularization with photodynamic therapy in age-related macular degeneration","volume":"14","author":"Donati","year":"1999","journal-title":"Semin. Ophthalmol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archopht.117.9.1161","article-title":"Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of a single treatment in a phase 1 and 2 study","volume":"117","author":"Miller","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1001\/archopht.117.9.1161","article-title":"Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of retreatments in a phase 1 and 2 study","volume":"117","author":"Miller","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"ref_198","first-page":"1508.e1-25","article-title":"Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration","volume":"113","author":"Chakravarthy","year":"2006","journal-title":"Ophthalmology"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"e000257","DOI":"10.1136\/bmjophth-2018-000257","article-title":"Anti-VEGF intervention in neovascular AMD: Benefits and risks restated as natural frequencies","volume":"4","author":"Clearkin","year":"2019","journal-title":"BMJ Open Ophthalmol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"632307","DOI":"10.1155\/2014\/632307","article-title":"Anti-VEGF for the management of diabetic macular edema","volume":"2014","author":"Stefanini","year":"2014","journal-title":"J. Immunol. Res."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/1573399811666150615151324","article-title":"Anti-VEGF Therapy for Retinal Vein Occlusions","volume":"17","author":"Campa","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IIO.0000000000000027","article-title":"Current management of vitreous hemorrhage due to proliferative diabetic retinopathy","volume":"54","author":"Carvounis","year":"2014","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"212532","DOI":"10.7573\/dic.212532","article-title":"The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy","volume":"7","author":"Zhao","year":"2018","journal-title":"Drugs Context"},{"key":"ref_204","first-page":"Cd007920","article-title":"Anti-vascular endothelial growth factor for neovascular glaucoma","volume":"2","author":"Simha","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_205","first-page":"30","article-title":"Combination of intravitreal bevacizumab and peripheral photocoagulation: An alternative treatment in eales disease","volume":"2","author":"Cp","year":"2013","journal-title":"Med. Hypothesis Discov. Innov. Ophthalmol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12886-017-0469-4","article-title":"The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat\u2019s disease","volume":"17","author":"Li","year":"2017","journal-title":"BMC Ophthalmol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/2474126418782067","article-title":"Anti-VEGF for Management of Neovascularization of Iris and Neovascular Glaucoma","volume":"2","author":"Xia","year":"2018","journal-title":"J. Vitreoretinal Dis."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1645269","DOI":"10.1155\/2017\/1645269","article-title":"Use of Anti-VEGF Agents in Glaucoma Surgery","volume":"2017","author":"Slabaugh","year":"2017","journal-title":"J. Ophthalmol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/aos.13178","article-title":"Use of anti-vascular endothelial growth factor in the management of pterygium","volume":"95","author":"Mak","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"ref_210","first-page":"56","article-title":"Management of Retinopathy of Prematurity--Use of Anti-VEGF Therapy","volume":"7","author":"Tran","year":"2018","journal-title":"Asia Pac. J. Ophthalmol. (Phila)"},{"key":"ref_211","first-page":"235","article-title":"Intravitreal bevacizumab for pseudophakic cystoid macular edema; a systematic review","volume":"7","author":"Parvaresh","year":"2012","journal-title":"J. Ophthalmic. Vis. Res."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"i33","DOI":"10.1093\/annonc\/mdw093","article-title":"Anti-angiogenic agents in ovarian cancer: Past, present, and future","volume":"27","author":"Monk","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10120-014-0397-4","article-title":"Vascular endothelial growth factor a inhibition in gastric cancer","volume":"18","author":"Park","year":"2015","journal-title":"Gastric. Cancer"},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Melegh, Z., and Oltean, S. (2019). Targeting Angiogenesis in Prostate Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112676"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1634\/theoncologist.2015-0295","article-title":"S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors","volume":"20","author":"Blanke","year":"2015","journal-title":"Oncologist"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1200\/JCO.2008.20.0238","article-title":"Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer","volume":"27","author":"Vervenne","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_217","first-page":"19","article-title":"Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?","volume":"3","author":"Korpanty","year":"2011","journal-title":"J. Thorac. Dis."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.ophtha.2014.05.009","article-title":"Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration","volume":"121","author":"Ho","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.ophtha.2015.08.009","article-title":"Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration: TREX-AMD 1-Year Results","volume":"122","author":"Wykoff","year":"2015","journal-title":"Ophthalmology"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ajo.2007.12.029","article-title":"Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): Year 2 results","volume":"145","author":"Antoszyk","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Schauwvlieghe, A.M., Dijkman, G., Hooymans, J.M., Verbraak, F.D., Hoyng, C.B., Dijkgraaf, M.G., Peto, T., Vingerling, J.R., and Schlingemann, R.O. (2016). Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153052"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ophtha.2014.07.041","article-title":"Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol","volume":"122","author":"Berg","year":"2015","journal-title":"Ophthalmology"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results","volume":"119","author":"Martin","year":"2012","journal-title":"Ophthalmology"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ophtha.2013.06.020","article-title":"Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial","volume":"120","author":"Kodjikian","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(13)61501-9","article-title":"Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial","volume":"382","author":"Chakravarthy","year":"2013","journal-title":"Lancet"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","article-title":"HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration","volume":"127","author":"Dugel","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ophtha.2014.03.026","article-title":"Safety and efficacy of conbercept in neovascular age-related macular degeneration: Results from a 12-month randomized phase 2 study: AURORA study","volume":"121","author":"Li","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ajo.2018.08.026","article-title":"Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study","volume":"197","author":"Liu","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_232","first-page":"1212","article-title":"Efficacy and safety of faricimab every 16 or 12 weeks for neovascular age-related macular degeneration: STAIRWAY phase 2 results","volume":"60","author":"Danzig","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Lien, S., and Lowman, H.B. (2008). Therapeutic anti-VEGF antibodies. Handb. Exp. Pharm., 131\u2013150.","DOI":"10.1007\/978-3-540-73259-4_6"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2165\/00003495-200767080-00007","article-title":"Ranibizumab","volume":"67","author":"Blick","year":"2007","journal-title":"Drugs"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"van Asten, F., Michels, C.T.J., Hoyng, C.B., van der Wilt, G.J., Klevering, B.J., Rovers, M.M., and Grutters, J.P.C. (2018). The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration-A cost-effectiveness analysis from a societal perspective. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197670"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat. Med."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrd3700","article-title":"Aflibercept","volume":"11","author":"Stewart","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bcp.2019.07.021","article-title":"Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF\/ERK pathway","volume":"168","author":"Lazzara","year":"2019","journal-title":"Biochem. Pharm."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fimmu.2017.00653","article-title":"Camelid Single-Domain Antibodies As an Alternative to Overcome Challenges Related to the Prevention, Detection, and Control of Neglected Tropical Diseases","volume":"8","author":"Fernandes","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_241","first-page":"3025","article-title":"Preclinical Pharmacology and Safety of ESBA1008, a Single-chain Antibody Fragment, Investigated as Potential Treatment for Age Related Macular Degeneration","volume":"53","author":"Gaudreault","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Plyukhova, A.A., Budzinskaya, M.V., Starostin, K.M., Rejdak, R., Bucolo, C., Reibaldi, M., and Toro, M.D. (2020). Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051522"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11095-008-9718-9","article-title":"The Pharmacology Study of a New Recombinant Human VEGF Receptor-Fc Fusion Protein on Experimental Choroidal Neovascularization","volume":"26","author":"Zhang","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"108083","DOI":"10.1016\/j.diabres.2020.108083","article-title":"Comparison of aqueous humor levels of PlGF and VEGF in proliferative diabetic retinopathy before and after intravitreal conbercept injection","volume":"162","author":"Zhang","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.15252\/emmm.201505889","article-title":"Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases","volume":"8","author":"Regula","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s40265-014-0333-2","article-title":"Ripasudil: First global approval","volume":"74","year":"2014","journal-title":"Drugs"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12886-020-01400-5","article-title":"Ripasudil alleviated the inflammation of RPE cells by targeting the miR-136-5p\/ROCK\/NLRP3 pathway","volume":"20","author":"Gao","year":"2020","journal-title":"BMC Ophthalmol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1167\/iovs.08-3253","article-title":"rAAV.sFlt-1 Gene Therapy Achieves Lasting Reversal of Retinal Neovascularization in the Absence of a Strong Immune Response to the Viral Vector","volume":"50","author":"Lai","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ajo.2019.03.006","article-title":"Three-Year Follow-Up of Phase 1 and 2a rAAV.sFLT-1 Subretinal Gene Therapy Trials for Exudative Age-Related Macular Degeneration","volume":"204","author":"Rakoczy","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ebiom.2016.11.016","article-title":"Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration","volume":"14","author":"Constable","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_252","unstructured":"(2020, October 15). EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04437368."},{"key":"ref_253","unstructured":"(2020, October 15). RGX-314 Gene Therapy for Neovascular AMD Trial, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03066258."},{"key":"ref_254","unstructured":"(2020, October 15). Safety and Tolerability Study of AAV2-sFLT01 in Patients with Neovascular Age-Related Macular Degeneration (AMD), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01024998."},{"key":"ref_255","unstructured":"(2020, October 15). Study of AdGVPEDF.11D in Neovascular Age-Related Macular Degeneration (AMD), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00109499."},{"key":"ref_256","unstructured":"(2020, October 15). A Follow-up Study to Evaluate the Safety of RetinoStat\u00ae in Patients with Age-Related Macular Degeneration, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01678872."},{"key":"ref_257","unstructured":"(2020, October 15). Safety and Efficacy Study of rAAV.sFlt-1 in Patients with Exudative Age-Related Macular Degeneration, Available online: https:\/\/ClinicalTrials.gov\/show\/NCT01494805."},{"key":"ref_258","unstructured":"(2020, October 15). AAVCAGsCD59 for the Treatment of Wet AMD, Available online: https:\/\/ClinicalTrials.gov\/show\/NCT03585556."},{"key":"ref_259","unstructured":"(2020, October 15). ADVM-022 Intravitreal Gene Therapy for Wet AMD, Available online: https:\/\/ClinicalTrials.gov\/show\/NCT03748784."},{"key":"ref_260","unstructured":"Regenxbio Inc. (2020, October 15). Long-Term Follow-Up Study of RGX-314, Available online: https:\/\/ClinicalTrials.gov\/show\/NCT03999801: 2019."},{"key":"ref_261","unstructured":"Figueroa, A.G., Boyd, B.M., Christensen, C.A., Javid, C.G., McKay, B.S., Fagan, T.C., and Snyder, R.W. (2020). Levodopa Positively Affects Neovascular Age-Related Macular Degeneration. Am. J. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/3\/1170\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:15:06Z","timestamp":1760159706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/3\/1170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":261,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ijms22031170"],"URL":"https:\/\/doi.org\/10.3390\/ijms22031170","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]}}}